Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
British Journal of Clinical Pharmacology|February 16, 2026
Ocrelizumab-induced colitis: VigiBase disproportionality analysis, case reports and literature reviewAudrey Fresse, Christophe Hommel, Nadine Petitpain, et al.Journal of Medical Case Reports|April 1, 2026
Complication after knee intra-articular betamethasone injection, a thrombocytopenic purpura: a case reportMarine Fauny, Audrey Fresse, Damien Loeuille, et al.Therapie|April 24, 2024
Profile of adverse drug reactions reported via the Continuum+ platform: Results from three-year regional follow-upJuliette Henry, Audrey Fresse, Mathilde Beurrier, et al.British Journal of Clinical Pharmacology|March 30, 2022
Psoriasis risk after beta-blocker exposure: Description of a pharmacovigilance signalBrahim Azzouz, Apolline De Guizelin, Aude Lambert, et al.Fundamental & Clinical Pharmacology|January 6, 2023
Drug-induced radiation recall reactions and non-anticancer drugs: A descriptive analysis from VigiBase®Eyrian Aubin-Beale, Lorene Giorgi, Mathilde Beurrier, et al.Therapie|February 5, 2025
Lichenoid drug eruption and apalutamide: Analyses from pharmacovigilance databases and disproportionality analysisViktoryia Prontskus, Anne Lise Pinault, Lucie-Marie Scailteux, et al.Fundamental & Clinical Pharmacology|January 24, 2023
Radiological evolution of progestogen-induced meningioma: A monocentric retrospective studyTaghla Ahmed-Khalifa, Romain Gillet, Marie Blonski, et al.Joint Bone Spine|June 4, 2023
Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance DatabaseClaire Amigues, Audrey Fresse, Christian Hubert Roux, et al.AIDS (London, England)|March 14, 2024
Adverse drug reaction profile of third-generation smallpox vaccines used in France during the 2022 monkeypox epidemicAudrey Fresse, Nathalie Massy, Dorine Fournier, et al.International Journal of Cardiology|October 19, 2020
Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problemAudrey Fresse, Delphine Viard, Serena Romani, et al.Pageof 3